24744728|t|Differential role of CSF alpha-synuclein species, tau, and Abeta42 in Parkinson's Disease.
24744728|a|There is a great interest in developing cerebrospinal fluid (CSF) biomarkers for diagnosis and prognosis of Parkinson's disease (PD). CSF alpha synuclein (alpha-syn) species, namely total and oligomeric alpha-syn (t-alpha-syn and o-alpha-syn), have shown to be of help for PD diagnosis. Preliminary evidences show that the combination of CSF t-alpha-syn and classical Alzheimer's disease (AD) biomarkers-beta-amyloid 1-42 (Abeta42), total tau (t-tau), phosphorylated tau (p-tau)-differentiate PD patients from controls, and that reduced levels of Abeta42 represent a predictive factor for development of cognitive deterioration in PD. In this prospective study carried out in 44 PD patients and 25 neurological controls we wanted to verify whether the combination of CSF alpha-synuclein species-t-alpha-syn and o-alpha-syn-and classical AD biomarkers may help in differentiating PD from neurological controls, and if these biomarkers may predict cognitive decline. The median of follow-up duration was 3 years (range: 2-6 years). Mini Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) were used for monitoring cognitive changes along time, being administered once a year. Oligo/total alpha-syn ratio (o/t-alpha-syn ratio) confirmed its diagnostic value, significantly contributing to the discrimination of PD from neurological controls. A greater diagnostic accuracy was reached when combining o/t-alpha-syn and Abeta42/tau ratios (Sens = 0.70, Spec = 0.84, AUC = 0.82; PPV = 0.89, NPV = 0.62, LR+ = 4.40, DOR = 12.52). Low CSF Abeta42 level was associated with a higher rate of MMSE and MoCA decline, confirming its role as independent predictive factor for cognitive decline in PD. None of the other biomarkers assessed (t-tau, p-tau, t-alpha-syn and o-alpha-syn) showed to have prognostic value. We conclude that combination of CSF o/t-alpha-syn and Abeta42/tau ratios improve the diagnostic accuracy of PD. PD patients showing low CSF Abeta42 levels at baseline are more prone to develop cognitive decline. 
24744728	25	40	alpha-synuclein	Gene	6622
24744728	50	53	tau	Gene	4137
24744728	59	66	Abeta42	Gene	351
24744728	70	89	Parkinson's Disease	Disease	MESH:D010300
24744728	199	218	Parkinson's disease	Disease	MESH:D010300
24744728	220	222	PD	Disease	MESH:D010300
24744728	229	244	alpha synuclein	Gene	6622
24744728	246	255	alpha-syn	Gene	6622
24744728	294	303	alpha-syn	Gene	6622
24744728	307	316	alpha-syn	Gene	6622
24744728	323	332	alpha-syn	Gene	6622
24744728	364	366	PD	Disease	MESH:D010300
24744728	435	444	alpha-syn	Gene	6622
24744728	459	478	Alzheimer's disease	Disease	MESH:D000544
24744728	480	482	AD	Disease	MESH:D000544
24744728	514	521	Abeta42	Gene	351
24744728	530	533	tau	Gene	4137
24744728	537	540	tau	Gene	4137
24744728	558	561	tau	Gene	4137
24744728	565	568	tau	Gene	4137
24744728	584	586	PD	Disease	MESH:D010300
24744728	587	595	patients	Species	9606
24744728	638	645	Abeta42	Gene	351
24744728	695	718	cognitive deterioration	Disease	MESH:D003072
24744728	722	724	PD	Disease	MESH:D010300
24744728	770	772	PD	Disease	MESH:D010300
24744728	773	781	patients	Species	9606
24744728	862	877	alpha-synuclein	Gene	6622
24744728	888	897	alpha-syn	Gene	6622
24744728	904	913	alpha-syn	Gene	6622
24744728	928	930	AD	Disease	MESH:D000544
24744728	970	972	PD	Disease	MESH:D010300
24744728	1037	1054	cognitive decline	Disease	MESH:D003072
24744728	1298	1307	alpha-syn	Gene	6622
24744728	1319	1328	alpha-syn	Gene	6622
24744728	1420	1422	PD	Disease	MESH:D010300
24744728	1512	1521	alpha-syn	Gene	6622
24744728	1526	1533	Abeta42	Gene	351
24744728	1534	1537	tau	Gene	4137
24744728	1642	1649	Abeta42	Gene	351
24744728	1773	1790	cognitive decline	Disease	MESH:D003072
24744728	1794	1796	PD	Disease	MESH:D010300
24744728	1839	1842	tau	Gene	4137
24744728	1846	1849	tau	Gene	4137
24744728	1853	1862	alpha-syn	Gene	6622
24744728	1869	1878	alpha-syn	Gene	6622
24744728	1953	1962	alpha-syn	Gene	6622
24744728	1967	1974	Abeta42	Gene	351
24744728	1975	1978	tau	Gene	4137
24744728	2021	2023	PD	Disease	MESH:D010300
24744728	2025	2027	PD	Disease	MESH:D010300
24744728	2028	2036	patients	Species	9606
24744728	2053	2060	Abeta42	Gene	351
24744728	2106	2123	cognitive decline	Disease	MESH:D003072
24744728	Association	MESH:D000544	4137
24744728	Association	MESH:D000544	351
24744728	Association	MESH:D000544	6622
24744728	Negative_Correlation	MESH:D003072	351
24744728	Association	MESH:D010300	351
24744728	Association	MESH:D010300	6622
24744728	Association	MESH:D010300	4137

